1. Outcome after pulmonary endarterectomy for segmental chronic thromboembolic pulmonary hypertension
- Author
-
Marc, de Perrot, Laura, Donahoe, Karen, McRae, John, Thenganatt, Jakov, Moric, Justin, Chan, Micheal, McInnis, Klaudia, Jumaa, Kong Teng, Tan, Sebastian, Mafeld, and John, Granton
- Subjects
Pulmonary and Respiratory Medicine ,Canada ,Treatment Outcome ,Hypertension, Pulmonary ,Chronic Disease ,Humans ,Surgery ,Endarterectomy ,Prospective Studies ,Pulmonary Artery ,Pulmonary Embolism ,Cardiology and Cardiovascular Medicine ,Retrospective Studies - Abstract
Determine the long-term outcome and need for additional therapy after pulmonary endarterectomy (PEA) for segmental chronic thromboembolic pulmonary hypertension.Retrospective analysis of a prospective cohort of 401 consecutive Canadian patients undergoing PEA between August 2005 and March 2020 in Toronto. The outcome of segmental disease defined as Jamieson type 3 was compared with more proximal disease defined as Jamieson type 1 and 2. The cohort was divided into 3 intervals to analyze the trend over time: 2005-2010, 2011-2015, and 2016-2020.Type 3 disease accounted for 41% of patients undergoing PEA durig 2016-2020 compared with 7% in 2006-2010. Total pulmonary vascular resistance improved by 505 ± 485 dynes/s/cmPEA achieved excellent early and long-term results in segmental chronic thromboembolic pulmonary hypertension. However, patients with segmental disease are at increased risk of requiring additional therapy after PEA and should be carefully monitored.
- Published
- 2022
- Full Text
- View/download PDF